Table 2.
Patient characteristics (n = 553).
Rivaroxaban | Apixaban | Edoxaban | All | |
---|---|---|---|---|
Patients (n/%) | 300 (54.3) | 221 (40.0) | 32 (5.7) | 553 (100) |
Age (median/IQR) | 74 (63–83) | 78 (67–82) | 75 (58–81) | 76 (65–82) |
Female sex (n/%) | 126 (40.1) | 86 (39.8) | 10 (32.3) | 222 (40.1) |